Find stats on top websites
The Fintech and Healthtech industries are undergoing rapid digital transformation, driven by emerging technologies like AI, increased demand for digital services, and stringent regulatory requirements. Companies are prioritizing secure, compliant, and scalable software solutions. Nearshore outsourcing is gaining traction as a cost-effective alternative to traditional models, offering cultural alignment and time zone advantages.
Total Assets Under Management (AUM)
Digital Transformation Market Size in United States
~Approximately $800 billion USD (2024 projection)
(15-20% CAGR)
- Driven by cloud adoption and data analytics.
- Increased focus on cybersecurity and AI.
- Significant investment in industry-specific solutions.
800 billion USD
Generative AI, particularly Large Language Models (LLMs), will revolutionize personalized financial advice, fraud detection, and automated patient support, enhancing efficiency and accessibility.
Blockchain and DLT will enhance data security, transparency, and interoperability in financial transactions and healthcare records, reducing fraud and streamlining processes.
Federated Learning allows AI models to train on decentralized datasets without directly accessing raw data, crucial for maintaining privacy in highly regulated Fintech and Healthtech environments.
While enacted in 2009, HITECH's enforcement, particularly around information blocking and data exchange, continues to evolve, pushing for greater interoperability and access to electronic health information.
This policy directly impacts Healthtech companies by requiring them to ensure their software facilitates secure and seamless exchange of patient data, increasing the demand for compliant integration and interoperability solutions.
CFPB is actively working on rules under Section 1033 of the Dodd-Frank Act to give consumers more control over their financial data, similar to HIPAA for health data, promoting open banking.
This regulation will compel Fintech companies to develop secure APIs and data portability features, creating a significant demand for robust data infrastructure and privacy-preserving technologies.
The FDA is piloting a 'Pre-Cert' program to streamline market authorization for software as a medical device (SaMD) by evaluating companies' quality management systems rather than individual products, fostering innovation.
This program could accelerate the development and deployment of new Healthtech software, benefiting companies like Softedge by potentially reducing time-to-market for compliant solutions and increasing demand for rapid, high-quality development.
Sign up now and unleash the power of AI for your business growth